Sign in

CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
113516358
Phone
(984) 884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
  1. 8-K Event Executive or director change
  2. 8-K Event Material agreement
  3. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. UPLOAD Other SEC-generated Letter
  8. CERT Other Certification
  9. 8-A12B Other Registration of Securities
  10. 25 Other Notification of Removal from Listing
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 8-K Event Shareholder vote results
  18. 8-K Event Delisting notice · Regulation FD disclosure
  19. 10-Q Report Quarterly Report
  20. DEF 14A Proxy Proxy Statement

Page 27 of 54 · 1,070 filings